Group 1 - Oklo's shares have increased by 7.4% following the announcement of a new partnership and a bullish analyst rating [2][4][5] - The strategic partnership with Blykalla AB aims to enhance Oklo's presence in Europe, focusing on SMR technology, supply chain coordination, and regulatory insights, with Oklo investing approximately $5 million in Blykalla's next funding round [4][6] - Barclays has initiated coverage of Oklo with an overweight rating and a price target of $146, suggesting an upside of over 32% from the current share price of $110.53 [5][6] Group 2 - Barclays views Oklo as a leveraged opportunity in the SMR industry, highlighting its development, ownership, and operation of SMRs, which can lead to strong cash flows, supported by a 14-gigawatt backlog of nonbinding agreements [6] - Despite the positive outlook, there are risks associated with Oklo, including the lack of design approval from the U.S. Nuclear Regulatory Commission [7][8] - Analysts from The Motley Fool have identified other nuclear energy stocks that may present lower risk compared to Oklo [9][10]